Success Metrics

Clinical Success Rate
85.7%

Based on 6 completed trials

Completion Rate
86%(6/7)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Terminated
1(11%)

Phase Distribution

Ph phase_1
1
11%
Ph phase_4
4
44%
Ph phase_3
1
11%
Ph early_phase_1
1
11%

Phase Distribution

2

Early Stage

0

Mid Stage

5

Late Stage

Phase Distribution7 total trials
Early Phase 1First-in-human
1(14.3%)
Phase 1Safety & dosage
1(14.3%)
Phase 3Large-scale testing
1(14.3%)
Phase 4Post-market surveillance
4(57.1%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

75.0%

6 of 8 finished

Non-Completion Rate

25.0%

2 ended early

Currently Active

0

trials recruiting

Total Trials

9

all time

Status Distribution
Completed(6)
Terminated(2)
Other(1)

Detailed Status

Completed6
Terminated1
unknown1
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
9
Active
0
Success Rate
85.7%
Most Advanced
Phase 4

Trials by Phase

Early Phase 11 (14.3%)
Phase 11 (14.3%)
Phase 31 (14.3%)
Phase 44 (57.1%)

Trials by Status

completed667%
terminated111%
unknown111%
withdrawn111%

Recent Activity

Clinical Trials (9)

Drug Details

Intervention Type
DRUG
Total Trials
9